Skip to main content
. 2019 Sep 12;20(18):4524. doi: 10.3390/ijms20184524

Figure 1.

Figure 1

The Rev-erbα agonist GSK4112 inhibited pre-adipocyte viability. (A) The effect of Rev-erbα agonist GSK4112 (10 µM) on mRNA expression of Bmal1 in 3T3-L1 cells; (B) cell viability was detected by measuring CCK-8 levels after GSK4112 treatment for 24 h and 48 h. The absorbance values at 450 nm were measured. The statistical results represent the mean ± SEM, n = 3. ** p < 0.01.